Erlotinib and blood sodium decreased 
Erlotinib and blood sodium decreased Patient Reports February 11, 2012
Erlotinib Side Effects Report #5049846-X
Erlotinib side effect was reported by a Physician from UNITED STATES on June 23, 2006. Male patient, 48 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, malaise, neutrophil count increased, pyrexia, urine flow decreased, urine ketone body present. Erlotinib dosage: 100 MG, QD; ORAL. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5055970-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, 48 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, candidiasis, decreased appetite, dehydration, dysphagia, malaise, mucosal inflammation. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, AUGMENTIN, NYSTATIN, DURAGESIC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5203396-6
Erlotinib side effect was reported by a Physician from PERU on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, malabsorption, no therapeutic response. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized and became disabled. Patient died.
Erlotinib Side Effects Report #5517710-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, dehydration, disease progression, lymphocyte count decreased, thrombocytopenia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, COMPAZINE, DILAUDID, FLUCONAZOLE, GLYBURIDE, MIRALAX. Patient recovered.
Erlotinib Side Effects Report #5744847-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, blood sodium decreased, candidiasis, confusional state, dehydration, haematocrit decreased, haemoglobin decreased, herpes simplex
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5286241-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 31 years of age, weighting 180.3 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, enterocutaneous fistula, haematocrit decreased, platelet count increased, white blood cell count increased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5307805-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 02, 2007. Female patient, 31 years of age, weighting 180.3 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, enterocutaneous fistula, haematocrit decreased, platelet count increased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, AMBIEN, HYDROCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5481997-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, 71 years of age, weighting 166.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, haemoglobin decreased, heart rate increased, leukopenia, mucosal inflammation, neutrophil count decreased. Erlotinib dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ACIPHEX, IMITREX, NAPROXEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6140496-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, 65 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, dysphagia, mucosal inflammation, nausea
, white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder
, vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5266887-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Female patient, 71 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: areflexia, aspiration, bacterial infection
, blood creatine phosphokinase bb increased, blood sodium decreased, cardiac arrest , cardiac failure, cardiogenic shock, computerised tomogram abnormal. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TYLENOL, VITAMIN, ASPIRIN, ZANTAC, METOPROLOL TARTRATE, COMPAZINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #4931344-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Female patient, 67 years of age, weighting 173.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, breath sounds abnormal, cough, crepitations, dilatation atrial, lung infiltration, malignant neoplasm progression, non-small cell lung cancer, orthopnoea. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, PREDNISONE, COMBIVENT, NORVASC. Patient was hospitalized and became disabled. Patient died on 11/18/2005.
Erlotinib Side Effects Report #5500155-1
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Oct 10, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, disease progression, interstitial lung disease, lymphocyte percentage decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.
Erlotinib Side Effects Report #5578137-3
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Dec 17, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, interstitial lung disease, lymphocyte percentage decreased, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.
Erlotinib Side Effects Report #5839944-2
Erlotinib side effect was reported by a Physician from UNITED STATES on July 23, 2008. Male patient, 66 years of age, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatine increased, blood sodium decreased, blood urea increased, dehydration, gastrooesophageal reflux disease, hyperkalaemia, weight decreased. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5869626-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 19, 2008. Male patient, 66 years of age, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood creatinine increased, blood sodium decreased, blood urea increased, dehydration, dyspnoea, fall , gastrooesophageal reflux disease, hyperkalaemia. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died on 08/12/2008.Erlotinib Side Effects Report #4896286-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, bacteraemia, blood calcium decreased, blood sodium decreased, breath sounds abnormal, cardio-respiratory arrest, chest discomfort. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, ASPIRIN, LOVENOX, ADVAIR DISKUS, ALBUTEROL INHALER, MS CONTIN, PERCOCET, SIMETHICONE. Patient died on 11/01/2005.
Erlotinib Side Effects Report #5930424-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5956177-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5145872-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, 61 years of age, weighting 125.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood creatine increased, blood glucose increased, blood potassium increased, blood sodium decreased, blood urea increased, coagulopathy, hypoperfusion, international normalised ratio decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, NEXIUM, LIPITOR, COLACE, ZESTRIL, DILANTIN, RANITIDINE, TEGRETOL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5920061-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood sodium decreased, clostridium difficile colitis, dehydration, haemoglobin decreased, ileus, nausea
, pyrexia, small intestinal obstruction. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5309020-6
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Apr 05, 2007. Male patient, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood chloride decreased, blood cholesterol decreased, blood glucose decreased, blood sodium decreased, bronchial obstruction, disease progression, dyspnoea. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, AMITRIPTYLINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5125158-0
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 20, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: adrenal disorder, blood albumin decreased, blood alkaline phosphatase increased, blood chloride decreased, blood cholesterol decreased, blood glucose decreased, blood sodium decreased, buttock pain, computerised tomogram abnormal. Erlotinib dosage: unknown. During the same period patient was treated with OXYCODONE, AMITRIPTYLINE. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5148576-3
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 23, 2006. Female patient, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: adrenal disorder, atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood chloride decreased, blood cholesterol decreased, blood glucose decreased, blood sodium decreased, bronchial obstruction. Erlotinib dosage: unknown. During the same period patient was treated with OXYCODONE, AMITRIPTYLINE. Patient was hospitalized and became disabled. Patient died.
Erlotinib Side Effects Report #5527205-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 07, 2007. Female patient, 79 years of age, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, ataxia
, atelectasis, blood chloride increased, blood sodium decreased, blood urea increased, cardiac disorder, constipation , dehydration. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient died.Erlotinib Side Effects Report #5215813-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2007. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, candidiasis, dysphagia, haemoglobin decreased, hiccups, mucosal inflammation, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5088038-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, condition aggravated, haemoglobin decreased, hiccups, neutrophil count decreased, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578433-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 10, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, blood sodium decreased, blood urea increased, blood urea nitrogen/creatinine ratio increased, breath sounds abnormal, constipation
, dehydration, diarrhoea, dysphagia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5176325-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 52 years of age, was diagnosed with laryngeal cancer, disease progression and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, diarrhoea, faecal incontinence, haemoglobin decreased, lobar pneumonia, loss of consciousness, malignant neoplasm progression, metastases to bone. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, PEMETREXED. Patient was hospitalized. Patient died on 11/07/2006.
Erlotinib Side Effects Report #5194077-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient, 52 years of age, was diagnosed with laryngeal cancer, disease progression and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood sodium decreased, diarrhoea, faecal incontinence, haemoglobin decreased, hypoxia, international normalised ratio increased, laryngeal cancer. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, PEMETREXED. Patient was hospitalized. Patient died on 11/07/2006.
Erlotinib Side Effects Report #6088056-4
Erlotinib side effect was reported by a Physician from HONG KONG on Feb 05, 2009. Male patient, 75 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal sepsis, blood creatinine increased, blood potassium decreased, blood sodium decreased, blood urea increased, cardiac arrest
, diarrhoea, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: (25 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ALLOPURINOL, ATENOLOL, PEPCIDINE, NAPROXEN. Patient was hospitalized. Patient died on 12/02/2008.Erlotinib Side Effects Report #5963873-7
Erlotinib side effect was reported by a Physician from DENMARK on Nov 05, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aphasia
, blood sodium decreased, headache , hypertension, ill-defined disorder, nausea , thyroid disorder. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5284210-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood sodium decreased, eye infection
, fatigue, nausea , oral discomfort, staphylococcal infection . Erlotinib dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.